Decision

2022 discharge: European Medicines Agency

Effect: Adopted
Result: 528 for · 71 against · 4 abstained roll call
Date: 11 April 2024, 13:10
Kind: Resolution

More facts (8)

Margin: by an overwhelming majority
Text: Report A-9-2024-0133
Dossier: 2023-2156
Source: Committee report by Petri Sarvamaa
Votes: 6 votes · 5 roll calls · 4 amendments
Requested by: ECR (1 roll call)
Sitting: Thursday 11 April 2024
Final vote: 167258

Margin: by an overwhelming majority
Text: Report A-9-2024-0133
Dossier: 2023-2156
Source: Committee report by Petri Sarvamaa
Votes: 6 votes · 5 roll calls · 4 amendments
Requested by: ECR (1 roll call)
Sitting: Thursday 11 April 2024
Final vote: 167258

Cite this page Roll-call results (EP)

Link to this page

Votes on this decision

Members on the final vote

Result

The final vote and what it means for this kind of decision.

Adopted by an overwhelming majority.

Parliament adopted the text as its official position.

Before the final vote, MEPs decided on 4 amendments (4 rejected).

Backed by The Left, Greens, S&D, Renew, EPP and ECR; opposed by Patriots and ESN.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
The Left	For 11	Against 1	Abst. 0	Majority line For	Clear line For
Greens	For 24	Against 0	Abst. 0	Majority line For	Clear line For
S&D	For 56	Against 1	Abst. 0	Majority line For	Clear line For
Renew	For 39	Against 0	Abst. 0	Majority line For	Clear line For
EPP	For 80	Against 1	Abst. 0	Majority line For	Clear line For
ECR	For 23	Against 3	Abst. 0	Majority line For	Clear line For
Patriots	For 5	Against 21	Abst. 0	Majority line Against	Clear line Against
ESN	For 0	Against 4	Abst. 0	Majority line Against	Clear line Against
No group	For 2	Against 3	Abst. 0	Majority line Against	Clear line Divided

Voted against their group, 0

Members who voted otherwise than a clear line (at least two thirds of the votes cast) of their group — groups as of today: the view with groups at the date of the vote is not available right now.

Nobody voted against a clear line of their group.

Countries

The final vote by national delegation.

The breakdown by country is not available right now.

Members

Each member’s recorded position on the final roll call — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 603 members

Debate speakers and how they voted

The debate speakers are not available right now.

All votes on this decision, 6

In voting order. **Result**: for–against–abstained (a show of hands has no count). **Requested by**: the groups that asked for a roll call, a split vote or a separate vote.
No.	Vote	Recorded	Result	Requested by
1	Proposals for decisions	Show of hands	Adopted
2	Amendment 1, adding text after paragraph 2 A9-0133/2024 – Petri Sarvamaa – After § 2 – Am 1	Roll call	225 for, 345 against, 32 abstained Rejected	Requested byroll call: ECR
3	Amendment 2, adding text after paragraph 5 A9-0133/2024 – Petri Sarvamaa – After § 5 – Am 2	Roll call	96 for, 485 against, 17 abstained Rejected	Requested byroll call: ECR

Show the other 5 votesShow the other 3 votes

Votes on this decision, continued
No.	Vote	Recorded	Result	Requested by
2	Amendment 1, adding text after paragraph 2 A9-0133/2024 – Petri Sarvamaa – After § 2 – Am 1	Roll call	225 for, 345 against, 32 abstained Rejected	Requested byroll call: ECR
3	Amendment 2, adding text after paragraph 5 A9-0133/2024 – Petri Sarvamaa – After § 5 – Am 2	Roll call	96 for, 485 against, 17 abstained Rejected	Requested byroll call: ECR

Votes on this decision, continued
No.	Vote	Recorded	Result	Requested by
4	Amendment 3, adding text after paragraph 7 A9-0133/2024 – Petri Sarvamaa – After § 7 – Am 3	Roll call	78 for, 485 against, 34 abstained Rejected	Requested byroll call: ECR
5	Amendment 4, adding text after paragraph 7 A9-0133/2024 – Petri Sarvamaa – After § 7 – Am 4	Roll call	94 for, 454 against, 53 abstained Rejected	Requested byroll call: ECR
6	Final vote — text as a whole A9-0133/2024 – Petri Sarvamaa – Motion for a resolution (as a whole)	Roll call	528 for, 71 against, 4 abstained Adopted

Roll call requested by ECR.

Text

The text voted on.

Report A-9-2024-0133

The text in short Written by AI from the official text — check the source

Parliament's Committee on Budgetary Control proposes granting discharge to the Executive Director of the European Medicines Agency for the 2022 budget and approving the closure of the Agency's 2022 accounts.

Read the text · Report a problem

Dossier

Where the dossier stands and its other decisions in plenary.

2023/2156(DEC) · Discharge procedure

Completed: published in the Official Journal on 10 October 2024 and now EU law.

Show the 5 steps of the dossier

Referred to committee · 12 September 2023 (done)
Committee work · Report adopted 4 March 2024 (done)
Tabled for plenary · 19 March 2024 (done)
Plenary vote · Adopted 11 April 2024 (done)
Parliament’s position · Final (done)

Lead committee: CONT · Author: MEP #112611 (EPP)

Connections

What this decision touches: the procedural chain, the same text, running issues, votes that split the chamber the same way.

No connections found for this decision.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/decisions/2024-04-11/26
Official sources: Roll-call votes, sitting of 11 April 2024 (European Parliament)
Results of votes, sitting of 11 April 2024 (European Parliament)
Data source: EP Open Data API: decisions of the sitting MTG-PL-2024-04-11
Licensed CC BY 4.0.
Retrieved: 26 September 2026

Cite as

European Parliament (2024). “2022 discharge: European Medicines Agency”. Decision, 11 April 2024. votingId 167258, document A-9-2024-0133, reference 2023-2156. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/decisions/2024-04-11/26 (retrieved 26 September 2026). Official sources: Roll-call votes, sitting of 11 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-RCV_EN.html; Results of votes, sitting of 11 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-11, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-11/decisions?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-decision-2024-04-11-26,
  author = {{European Parliament}},
  title = {{2022 discharge: European Medicines Agency}},
  year = {2024},
  date = {2024-04-11},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/decisions/2024-04-11/26}},
  url = {https://news.eu-parl.st-solutions.dev/decisions/2024-04-11/26},
  urldate = {2026-09-26},
  publisher = {EU Parl Watch Research},
  note = {Decision. votingId 167258, document A-9-2024-0133, reference 2023-2156. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-11-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-11 (CC BY 4.0)}
}